Skip to main content

Advertisement

Erratum to: Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice

Article metrics

The original article was published in Genetic Vaccines and Therapy 2008 6:13

Correction

Since publication of our article [1], it has come to our attention that the alpha-myosin heavy chain promoter was incorrectly identified as being of human origin. The correct origin of the promoter was from mouse.

The corrections within the text are as follows:

Under the heading Findings, 5 paragraph, line 3: "human alpha-myosin heavy chain" should be "murine alpha-myosin heavy chain."

Under the heading Findings, 8th paragraph, line 1: "The human a-MHC promoter" should be "The murine a-MHC promoter"

Figure 1, Figure legend, line 6; "...created by amplifying human genomic DNA" should be "... created by amplifying mouse genomic DNA."

The authors regret the error and any inconveniences to the readers. The results and conclusions of this article remain unchanged.

References

  1. 1.

    Pacak CA, Sakai Y, Thattaliyath BD, Mah CS, Byrne BJ: Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice. Genetic Vaccines and Therapy. 2008, 6: 13. 10.1186/1479-0556-6-13.

Download references

Author information

Correspondence to Cathryn S Mah or Barry J Byrne.

Additional information

The online version of the original article can be found at 10.1186/1479-0556-6-13

Christina A Pacak, Yoshihisa Sakai contributed equally to this work.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Pacak, C.A., Sakai, Y., Thattaliyath, B.D. et al. Erratum to: Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice. Genet Vaccines Ther 7, 3 (2009) doi:10.1186/1479-0556-7-3

Download citation